Susceptibility of Enterobacteriaceae to [beta]-lactam agents and fluoroquinolones: a 3-year survey in France
Objective To assess trends in the susceptibility to [beta]-lactam agents and to fluoroquinolones of clinically relevant Enterobacteriaceae isolated over a 3-year period in 14 French hospital laboratories. Methods During the second quarter of 1996, 1997 and 1998, 180 consecutive non-duplicate isolate...
Gespeichert in:
| Veröffentlicht in: | Clinical microbiology and infection 2002-04, Vol.8 (4), p.207-213 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 213 |
|---|---|
| container_issue | 4 |
| container_start_page | 207 |
| container_title | Clinical microbiology and infection |
| container_volume | 8 |
| creator | Sirot, J Nicolas-Chanoine, M H Chardon, H Avril, J L Cattoen, C Croix, JC Dabernat, H Fosse, T Ghnassia, J C Lecaillon, E Marmonier, A Roussel-Delvallez, M Soussy, C J Trevoux, A Vandenesch, F Dib, C Moniot-Ville, N Rezvani, Y |
| description | Objective To assess trends in the susceptibility to [beta]-lactam agents and to fluoroquinolones of clinically relevant Enterobacteriaceae isolated over a 3-year period in 14 French hospital laboratories. Methods During the second quarter of 1996, 1997 and 1998, 180 consecutive non-duplicate isolates of Enterobacteriaceae were collected in each center. Sixteen [beta]-lactams and four quinolones were tested by the disk diffusion method. In addition, the double-disk synergy test was used to screen for the production of extended-spectrum [beta]-lactamase (ESBL). Results Totals of 2507, 2312 and 2506 clinical isolates were obtained in each period, respectively. The distribution of Enterobacteriaceae species according to clinical specimens and wards was similar in each study period. No significant variation in the susceptibility rates to [beta]-lactams and fluoroquinolones was observed, except in Klebsiella pneumoniae and Enterobacter aerogenes. The prevalence of ESBL-producing isolates decreased from 18% to 9% in the former, while it increased from 32% to 54% in the latter. At the same time, the susceptibility to ofloxacin and pefloxacin increased for K. pneumoniae (P |
| doi_str_mv | 10.1046/j.1469-0691.2002.00393.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1560118775</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1560118775</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_15601187753</originalsourceid><addsrcrecordid>eNqVjk9LAzEUxIMoWP98h3f0kpg0292uV2nxrgdBpLxd30pKmtS8RNxvbwTx7mmGmR_DCAFGK6Ob9navTNP2Ure9UUutl0pr21v1dSIWf8Vp9aZfy66xz-fignmvK2ltsxD-sfBIx-wG512eIU6wCZlSHHCs4nAkJMgRXgbK-Cp9jfEA-E4hM2B4g8mXmOJHcSH6GIjvAMHKmTABl_RJM7gA24RhpCtxNqFnuv7VS3Gz3TzdP8jjzwBx3h1cfeM9BoqFd2bVamPWXbey_0C_AXkgVfA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1560118775</pqid></control><display><type>article</type><title>Susceptibility of Enterobacteriaceae to [beta]-lactam agents and fluoroquinolones: a 3-year survey in France</title><source>Wiley Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Sirot, J ; Nicolas-Chanoine, M H ; Chardon, H ; Avril, J L ; Cattoen, C ; Croix, JC ; Dabernat, H ; Fosse, T ; Ghnassia, J C ; Lecaillon, E ; Marmonier, A ; Roussel-Delvallez, M ; Soussy, C J ; Trevoux, A ; Vandenesch, F ; Dib, C ; Moniot-Ville, N ; Rezvani, Y</creator><creatorcontrib>Sirot, J ; Nicolas-Chanoine, M H ; Chardon, H ; Avril, J L ; Cattoen, C ; Croix, JC ; Dabernat, H ; Fosse, T ; Ghnassia, J C ; Lecaillon, E ; Marmonier, A ; Roussel-Delvallez, M ; Soussy, C J ; Trevoux, A ; Vandenesch, F ; Dib, C ; Moniot-Ville, N ; Rezvani, Y</creatorcontrib><description>Objective To assess trends in the susceptibility to [beta]-lactam agents and to fluoroquinolones of clinically relevant Enterobacteriaceae isolated over a 3-year period in 14 French hospital laboratories. Methods During the second quarter of 1996, 1997 and 1998, 180 consecutive non-duplicate isolates of Enterobacteriaceae were collected in each center. Sixteen [beta]-lactams and four quinolones were tested by the disk diffusion method. In addition, the double-disk synergy test was used to screen for the production of extended-spectrum [beta]-lactamase (ESBL). Results Totals of 2507, 2312 and 2506 clinical isolates were obtained in each period, respectively. The distribution of Enterobacteriaceae species according to clinical specimens and wards was similar in each study period. No significant variation in the susceptibility rates to [beta]-lactams and fluoroquinolones was observed, except in Klebsiella pneumoniae and Enterobacter aerogenes. The prevalence of ESBL-producing isolates decreased from 18% to 9% in the former, while it increased from 32% to 54% in the latter. At the same time, the susceptibility to ofloxacin and pefloxacin increased for K. pneumoniae (P<0.003) and cephalosporinase-producing species (P<0.05), except Enterobacter spp. Conclusion Over the 3-year study period [beta]-lactams and fluoroquinolones remained highly active against Enterobacteriaceae clinical isolates, with the exception of E. aerogenes, probably as a result of the dissemination of multiresistant clones in French hospitals.</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1046/j.1469-0691.2002.00393.x</identifier><language>eng</language><subject>Enterobacter ; Enterobacter aerogenes ; Enterobacteriaceae ; Klebsiella pneumoniae</subject><ispartof>Clinical microbiology and infection, 2002-04, Vol.8 (4), p.207-213</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Sirot, J</creatorcontrib><creatorcontrib>Nicolas-Chanoine, M H</creatorcontrib><creatorcontrib>Chardon, H</creatorcontrib><creatorcontrib>Avril, J L</creatorcontrib><creatorcontrib>Cattoen, C</creatorcontrib><creatorcontrib>Croix, JC</creatorcontrib><creatorcontrib>Dabernat, H</creatorcontrib><creatorcontrib>Fosse, T</creatorcontrib><creatorcontrib>Ghnassia, J C</creatorcontrib><creatorcontrib>Lecaillon, E</creatorcontrib><creatorcontrib>Marmonier, A</creatorcontrib><creatorcontrib>Roussel-Delvallez, M</creatorcontrib><creatorcontrib>Soussy, C J</creatorcontrib><creatorcontrib>Trevoux, A</creatorcontrib><creatorcontrib>Vandenesch, F</creatorcontrib><creatorcontrib>Dib, C</creatorcontrib><creatorcontrib>Moniot-Ville, N</creatorcontrib><creatorcontrib>Rezvani, Y</creatorcontrib><title>Susceptibility of Enterobacteriaceae to [beta]-lactam agents and fluoroquinolones: a 3-year survey in France</title><title>Clinical microbiology and infection</title><description>Objective To assess trends in the susceptibility to [beta]-lactam agents and to fluoroquinolones of clinically relevant Enterobacteriaceae isolated over a 3-year period in 14 French hospital laboratories. Methods During the second quarter of 1996, 1997 and 1998, 180 consecutive non-duplicate isolates of Enterobacteriaceae were collected in each center. Sixteen [beta]-lactams and four quinolones were tested by the disk diffusion method. In addition, the double-disk synergy test was used to screen for the production of extended-spectrum [beta]-lactamase (ESBL). Results Totals of 2507, 2312 and 2506 clinical isolates were obtained in each period, respectively. The distribution of Enterobacteriaceae species according to clinical specimens and wards was similar in each study period. No significant variation in the susceptibility rates to [beta]-lactams and fluoroquinolones was observed, except in Klebsiella pneumoniae and Enterobacter aerogenes. The prevalence of ESBL-producing isolates decreased from 18% to 9% in the former, while it increased from 32% to 54% in the latter. At the same time, the susceptibility to ofloxacin and pefloxacin increased for K. pneumoniae (P<0.003) and cephalosporinase-producing species (P<0.05), except Enterobacter spp. Conclusion Over the 3-year study period [beta]-lactams and fluoroquinolones remained highly active against Enterobacteriaceae clinical isolates, with the exception of E. aerogenes, probably as a result of the dissemination of multiresistant clones in French hospitals.</description><subject>Enterobacter</subject><subject>Enterobacter aerogenes</subject><subject>Enterobacteriaceae</subject><subject>Klebsiella pneumoniae</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqVjk9LAzEUxIMoWP98h3f0kpg0292uV2nxrgdBpLxd30pKmtS8RNxvbwTx7mmGmR_DCAFGK6Ob9navTNP2Ure9UUutl0pr21v1dSIWf8Vp9aZfy66xz-fignmvK2ltsxD-sfBIx-wG512eIU6wCZlSHHCs4nAkJMgRXgbK-Cp9jfEA-E4hM2B4g8mXmOJHcSH6GIjvAMHKmTABl_RJM7gA24RhpCtxNqFnuv7VS3Gz3TzdP8jjzwBx3h1cfeM9BoqFd2bVamPWXbey_0C_AXkgVfA</recordid><startdate>20020401</startdate><enddate>20020401</enddate><creator>Sirot, J</creator><creator>Nicolas-Chanoine, M H</creator><creator>Chardon, H</creator><creator>Avril, J L</creator><creator>Cattoen, C</creator><creator>Croix, JC</creator><creator>Dabernat, H</creator><creator>Fosse, T</creator><creator>Ghnassia, J C</creator><creator>Lecaillon, E</creator><creator>Marmonier, A</creator><creator>Roussel-Delvallez, M</creator><creator>Soussy, C J</creator><creator>Trevoux, A</creator><creator>Vandenesch, F</creator><creator>Dib, C</creator><creator>Moniot-Ville, N</creator><creator>Rezvani, Y</creator><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>20020401</creationdate><title>Susceptibility of Enterobacteriaceae to [beta]-lactam agents and fluoroquinolones: a 3-year survey in France</title><author>Sirot, J ; Nicolas-Chanoine, M H ; Chardon, H ; Avril, J L ; Cattoen, C ; Croix, JC ; Dabernat, H ; Fosse, T ; Ghnassia, J C ; Lecaillon, E ; Marmonier, A ; Roussel-Delvallez, M ; Soussy, C J ; Trevoux, A ; Vandenesch, F ; Dib, C ; Moniot-Ville, N ; Rezvani, Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_15601187753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Enterobacter</topic><topic>Enterobacter aerogenes</topic><topic>Enterobacteriaceae</topic><topic>Klebsiella pneumoniae</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sirot, J</creatorcontrib><creatorcontrib>Nicolas-Chanoine, M H</creatorcontrib><creatorcontrib>Chardon, H</creatorcontrib><creatorcontrib>Avril, J L</creatorcontrib><creatorcontrib>Cattoen, C</creatorcontrib><creatorcontrib>Croix, JC</creatorcontrib><creatorcontrib>Dabernat, H</creatorcontrib><creatorcontrib>Fosse, T</creatorcontrib><creatorcontrib>Ghnassia, J C</creatorcontrib><creatorcontrib>Lecaillon, E</creatorcontrib><creatorcontrib>Marmonier, A</creatorcontrib><creatorcontrib>Roussel-Delvallez, M</creatorcontrib><creatorcontrib>Soussy, C J</creatorcontrib><creatorcontrib>Trevoux, A</creatorcontrib><creatorcontrib>Vandenesch, F</creatorcontrib><creatorcontrib>Dib, C</creatorcontrib><creatorcontrib>Moniot-Ville, N</creatorcontrib><creatorcontrib>Rezvani, Y</creatorcontrib><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sirot, J</au><au>Nicolas-Chanoine, M H</au><au>Chardon, H</au><au>Avril, J L</au><au>Cattoen, C</au><au>Croix, JC</au><au>Dabernat, H</au><au>Fosse, T</au><au>Ghnassia, J C</au><au>Lecaillon, E</au><au>Marmonier, A</au><au>Roussel-Delvallez, M</au><au>Soussy, C J</au><au>Trevoux, A</au><au>Vandenesch, F</au><au>Dib, C</au><au>Moniot-Ville, N</au><au>Rezvani, Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Susceptibility of Enterobacteriaceae to [beta]-lactam agents and fluoroquinolones: a 3-year survey in France</atitle><jtitle>Clinical microbiology and infection</jtitle><date>2002-04-01</date><risdate>2002</risdate><volume>8</volume><issue>4</issue><spage>207</spage><epage>213</epage><pages>207-213</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>Objective To assess trends in the susceptibility to [beta]-lactam agents and to fluoroquinolones of clinically relevant Enterobacteriaceae isolated over a 3-year period in 14 French hospital laboratories. Methods During the second quarter of 1996, 1997 and 1998, 180 consecutive non-duplicate isolates of Enterobacteriaceae were collected in each center. Sixteen [beta]-lactams and four quinolones were tested by the disk diffusion method. In addition, the double-disk synergy test was used to screen for the production of extended-spectrum [beta]-lactamase (ESBL). Results Totals of 2507, 2312 and 2506 clinical isolates were obtained in each period, respectively. The distribution of Enterobacteriaceae species according to clinical specimens and wards was similar in each study period. No significant variation in the susceptibility rates to [beta]-lactams and fluoroquinolones was observed, except in Klebsiella pneumoniae and Enterobacter aerogenes. The prevalence of ESBL-producing isolates decreased from 18% to 9% in the former, while it increased from 32% to 54% in the latter. At the same time, the susceptibility to ofloxacin and pefloxacin increased for K. pneumoniae (P<0.003) and cephalosporinase-producing species (P<0.05), except Enterobacter spp. Conclusion Over the 3-year study period [beta]-lactams and fluoroquinolones remained highly active against Enterobacteriaceae clinical isolates, with the exception of E. aerogenes, probably as a result of the dissemination of multiresistant clones in French hospitals.</abstract><doi>10.1046/j.1469-0691.2002.00393.x</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1198-743X |
| ispartof | Clinical microbiology and infection, 2002-04, Vol.8 (4), p.207-213 |
| issn | 1198-743X 1469-0691 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1560118775 |
| source | Wiley Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Enterobacter Enterobacter aerogenes Enterobacteriaceae Klebsiella pneumoniae |
| title | Susceptibility of Enterobacteriaceae to [beta]-lactam agents and fluoroquinolones: a 3-year survey in France |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T02%3A03%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Susceptibility%20of%20Enterobacteriaceae%20to%20%5Bbeta%5D-lactam%20agents%20and%20fluoroquinolones:%20a%203-year%20survey%20in%20France&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Sirot,%20J&rft.date=2002-04-01&rft.volume=8&rft.issue=4&rft.spage=207&rft.epage=213&rft.pages=207-213&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1046/j.1469-0691.2002.00393.x&rft_dat=%3Cproquest%3E1560118775%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1560118775&rft_id=info:pmid/&rfr_iscdi=true |